Graviton Bioscience
Andrew Wojcik has extensive experience in the pharmaceutical industry, holding various quality and compliance roles at companies such as Graviton Bioscience, Équilibre BioPharmaceuticals Corp., Kadmon, Lexicon Pharmaceuticals, Purdue Pharma L.P., and Forest Labs/Allergan. Andrew managed multiple audit functions in the GCP/GLP space for internal and external audit activities and served as the lead clinical QA representative on in-licensing/due diligence opportunities. With a Bachelor of Science degree in Accounting from The College of New Jersey, Andrew Wojcik also has a background in building and directing audit organizations for global pharma companies.
Graviton Bioscience
Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.